Blood Platelet Reactivity and its Pharmacological Modulation in (People with) Diabetes Mellitus

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|18|2331-2365

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.18, 2005-07, pp. : 2331-2365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal vascular reactivity to vasopressin in rats with diabetes mellitus

By Loichot C.   Anjuere J.   Nisato D.   De Jong W.   Imbs J.-L.   Barthelmebs M.  

European Journal of Pharmacology, Vol. 431, Iss. 3, 2001-11 ,pp. : 321-329

Elsevier

Access to resources Recommend Favorite

What is the Optimal Blood Pressure in Patients with Diabetes Mellitus?

By Nilsson P.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 3, 2001-03 ,pp. : 173-177

Adis International

Access to resources Recommend Favorite

Diabetes Mellitus-Associated Atherosclerosis: Mechanisms Involved and Potential for Pharmacological Invention

By Calkin Anna C.   Allen Terri J.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 1, 2006-01 ,pp. : 15-40

Adis International

Access to resources Recommend Favorite

Pharmacological Strategies to Reduce Cardiovascular Risk in Type 2 Diabetes Mellitus: An Update

By Marcel M.C. Hovens   Jouke T. Tamsma   Edith D. Beishuizen   Menno V. Huisman  

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 433-445

Adis International

Access to resources Recommend Favorite

Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus

By Forst Thomas   Pfützner Andreas  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2281-2296

Informa Healthcare

Access to resources Recommend Favorite